• Welcome Guest
  • View Cart
  • Phone (US): 703.778.3080
  • 0Shopping Cart
  • Market Reports
  • Market Research Subscriptions
    • Knowledge Center
  • Custom Market Research
    • Quantitative Market Research
    • Qualitative Market Research
    • RateMyProduct
  • Blog
  • Featured
    • Free Downloads
    • View Webinars On-Demand
    • The IVD Market in 2023: $130 Billion and Growing
    • The Point of Care Testing Market
    • Immunoassays
  • About Us
    • Contact
  • Search
  • Menu Menu
  • Biotechnology
    • Next Generation Sequencing
    • Proteomics
    • Biopharmaceuticals
    • Instrumentation & Equipment
    • Emerging Technologies
  • Pharmaceuticals
    • Vaccines
    • Drug Delivery
    • Over-the-Counter
    • Drug Discovery
    • Cancer Treatment
    • Manufacturing & Packaging
    • Prescription Drugs
  • Diagnostics
    • Molecular Assays
    • Point-of-Care
    • Immunoassays
    • Infectious Disease
    • Clinical Chemistry
    • Oncology & Hematology
    • Lab Testing Services
    • Medical Imaging
  • Healthcare
    • Information Technology
    • Facilities & Settings
    • Insurance & Managed Care
  • Medical Devices
    • Wound Care
    • Drug Delivery
    • Equipment
    • Surgical
  • Login
Awaiting product image

Filter your search

Search Report Keyword
Price
CATEGORIES
  • Biotechnology Market Research
  • cell and gene therapy
  • cell therapy
  • Diagnostics Market Research
  • gene therapy
  • Healthcare Information Technology
  • Healthcare Market Research
  • in vitro diagnostic
  • IVD
  • life sciences
  • Medical Devices Market Research
  • Molecular & Nucleic Acid Testing
  • Pharmaceuticals Market Research
  • Point-of-Care Diagnostics
  • sciences
  • vaccines

Knowledge Center Sidebar

Most Popular Research

  • Cell and Gene Therapy Business Outlook
  • The Worldwide Market for In Vitro Diagnostic Tests, 14th Edition
  • Clinical Diagnostics MasterFile
  • The Global Market for Medical Devices, 11th Edition
  • The World Market for Molecular Diagnostics Tests, 10th Edition
  • Remote Patient Monitoring and Telehealth Markets, 12th Edition

Women’s Health: Worldwide Prescription Drug Markets – 3rd Edition

$2,812.00 – $5,625.00

Clear
SKU: KLI821220 Categories: Pharmaceuticals Market Research, Prescription Drugs Market Reports Pages: 368
  • Description
  • Table of Contents
  • Latest reports

Description

During the last 25 years, there have been unprecedented advancements in the area of women’s health and there is widespread recognition of the importance of addressing conditions that overwhelmingly affect women. Likewise, pharmaceutical marketers have increasingly understood the potential that the women’s health market represents and the increasing clout female consumers are wielding in the prescription drug marketplace. Women’s Health: Worldwide Prescription Drug Markets is a comprehensive study of the pharmaceutical markets aimed at diseases and conditions that affect women.

Scope and Methodology

For this study, the worldwide prescription drug market for women’s health is discussed in total manufacturers’ revenues for the following product categories:

  • Autoimmune diseases
  • Cancer
  • Gynecological and Sexually Transmitted Diseases
  • Hormones
  • Osteoporosis
  • Urinary Disorders

The information and analysis presented in this report are based on an extensive survey of senior management in the prescription women’s health drug industry. Background information was obtained from a comprehensive search of published literature and reports obtained from various government, business, medical trade, and international journals. Key information from published literature was used to conduct interviews with over 62 industry executives and product managers to validate and obtain expert opinion on current and future trends in the women’s health industry. Interviews were also used to confirm and/or adjust market size and market share estimates, as well as in formulating market projections.

All market data are presented at the manufacturers’ level in current U.S dollars. The base year for data was 2002. Historical data are provided for each of the years 1997 through 2002, and forecast data are provided for each of the years 2003 through 2007. Historical, base year, and forecast data are provided for each market segment and subsegment. Market shares are provided for each market segment for the 2002 base year.

Table of Contents

Chapter One: Executive Summary

  • Scope and Methodology
  • Size and Growth of the Market
  • Total Market Size and Forecast
  • Trends Affecting the Market
  • Market Outlook

Chapter Two: Introduction and Overview

  • History of Women’s Health
  • Female Reproductive System
  • Hormone Regulation
  • Demographics
  • Incidence, Prevalence, Mortality
    • Autoimmune Disease
    • Cancer
    • Gynecological Infection and Sexually Transmitted Disease
    • Hormone-Related Indications
    • Osteoporosis
    • Urinary Bladder Disorders
    • Lifestyle Patterns

Chapter Three: Autoimmune Diseases

  • Overview
  • Chronic Fatigue Syndrome
    • Overview
    • Treatment
  • Fibromyalgia
    • Overview
    • Treatment
  • Rheumatoid Arthritis
    • Overview
    • Treatment
  • Scleroderma
    • Overview
    • Treatment
  • Sjogren’s Syndrome
    • Overview
    • Treatment
  • Systemic Lupus Erythematosus
    • Overview
    • Treatment
  • Market Size and Growth
  • Geographical Market Analysis
  • Research and Development
  • Competitive Market

Chapter Four: Cancer

Overview

Breast Cancer

  • Overview
  • Treatment

Cervical Cancer

  • Overview
  • Treatment

Endometrial Cancer

  • Overview
  • Treatment

Ovarian Cancer

  • Overview
  • Treatment

Vaginal Cancer

  • Overview
  • Treatment

Market Size and Growth

Geographical Market Analysis

Research and Development

Competitive Market

Chapter Five: Gynecological Infections and Sexually Transmitted Diseases

Overview

AIDS

  • Overview
  • Treatment

Bacterial Vaginosis

  • Overview
  • Treatment

Cervical Dysplasia

  • Overview
  • Treatment
  • Chlamydia
    • Overview
    • Treatment
  • Condyloma Acuminata
    • Overview
    • Treatment
  • Genital Herpes
    • Overview
    • Treatment
  • Gonorrhea
    • Overview
    • Treatment
  • Hepatitis
    • Overview
    • Treatment
  • Pelvic Inflammatory Disease
    • Overview
    • Treatment
  • Syphilis
    • Overview
    • Treatment
  • Toxic Shock Syndrome
    • Overview
    • Treatment
  • Yeast Infections
    • Overview
    • Treatment
  • Market Size and Growth
  • Geographical Market Analysis
  • Research and Development
  • Competitive Market

Chapter Six: Hormone-Related Disorders

  • Overview
  • Contraception
    • Overview
    • Treatment
  • Endometriosis
    • Overview
    • Treatment
  • Fibroids
    • Overview
    • Treatment
  • Infertility
    • Overview
    • Treatment
  • Menopause
    • Overview
    • Treatment
  • Menstrual Disorders
    • Amenorrhea
    • Dysmenorrhea
  • Sexual Dysfunction
    • Overview
    • Treatment
  • Market Size and Growth
  • Geographical Market Analysis
  • Research and Development
  • Competitive Market

Chapter Seven: Osteoporosis

  • Overview Market Size and Growth Geographical Market Analysis Research and Development Competitive Market

Chapter Eight: Urinary Bladder Disorders

  • Overview
  • Cystitis
    • Overview
    • Treatment
  • Incontinence
    • Overview
    • Treatment
    • Alternative Treatments
  • Interstitial Cystitis
    • Overview
    • Treatment
  • Market Size and Growth
  • Geographical Market Analysis
  • Research and Development
  • Competitive Market

Chapter Nine: Issues and Trends

  • 2003 Budget Increases for Women’s Health Issues
  • Women’s Health Initiative
  • What Now? Guidance for the Industry
  • Perimenopausal Use of Contraceptives
  • Fosamax Patents Void in European Market
  • Insurance Coverage for Contraceptives
  • HPV Vaccine
  • Foreign Girls and Young Women and HIV
  • Oral Contraceptives in Japan
  • Ovarian Cancer Test
  • Immunotherapies in Ovarian Cancer
  • New Pap Test Screening Guidelines
  • Estrogen Labeling
  • New Uterine Fibroid Treatment
  • Inequality in Clinical Testing of Drugs
  • Testing for Predisposition to Cancer
  • Osteoporosis Drug Opportunities in Asia

Chapter Ten: World Market Summary

  • Overview
  • Total Market Size and Forecast
  • Market Analysis

Chapter Eleven: Competitor Profiles

  • Industry Structure and Participants
  • Akzo Nobel NV (Organon)
  • Amgen, Inc.
  • AstraZeneca PLC
  • Aventis
  • Barr Laboratories, Inc.
  • Bristol-Myers Squibb Company
  • Eli Lilly and Company
  • GlaxoSmithKline
  • Johnson & Johnson
  • Merck & Company, Inc.
  • Novartis International AG
  • Pfizer, Inc.
  • Pharmacia Corporation
  • Procter & Gamble Company
  • Roche
  • Schering AG
  • Serono International S.A.
  • Wyeth

Appendix: Company Directory

List of Exhibits

  • Table 1-1: The Worldwide Market for Women’s Healthcare, Revenues by Segment, 1997-2007
  • Figure 1-1: The Market for Women’s Healthcare Revenues by Segment 1997-2007
  • Table 2-1: World Life Expectancy at Birth in Selected Countries by Sex, 2000
  • Figure 2-1: Female Advantage in Life Expectancy at Birth in Selected Countries, 2000 (Difference, in Years, between Females and Males)
  • Table 2-2: World Population Growth, by Total World Population and Selected Country or Regions and Selected Characteristics
  • Figure 2-2: World Population Growth by Sex 2000, 2002, 2010, 2020, 2025
  • Figure 2-3: United States Population Growth by Sex 2000, 2002, 2010, 2020, 2025
  • Figure 2-4: Five Major European Countries* Population Growth by Sex 2000, 2002, 2010, 2020, 2025
  • Figure 2-5: Japan Population Growth by Sex 2000, 2002, 2010, 2020, 2025
  • Table 2-3: World Female Population Growth by Selected Country or Regions and Selected Age Group
  • Figure 2-6: World Female Population Growth by Selected Age Group 2000, 2002, 2010, 2020, 2025
  • Figure 2-7: United States Female Population Growth by Selected Age Group 2000, 2002, 2010, 2020, 2025
  • Figure 2-8: Five Major European Countries Female Population Growth by Selected Age Group 2000, 2002, 2010, 2020, 2025
  • Figure 2-9: Japan Female Population Growth by Selected Age Group 2000, 2002, 2010, 2020, 2025
  • Table 2-4: Estimated Female Prevalence of Autoimmune Diseases by Type and Geographical Distribution
  • Table 2-5: Estimated Incidence of Female Cancers and Mortality by Type and Geographical Distribution
  • Table 2-6: Estimated Female Incidence and Prevalence Gynecological and Sexually Transmitted Diseases by Type and Geographical Distribution
  • Table 2-7: Gynecological and Sexually Transmitted Diseases Related Epidemiologic Data
  • Table 2-8: Estimated World and U.S. Female Incidence and Prevalence of Hormone-Related Disorders and Indications by Type
  • Table 2-9: Estimated World and U.S. Contraceptive Use by Method
  • Table 2-10: Estimated Female Prevalence of Osteoporosis by Type and Geographical Distribution
  • Table 2-11: Estimated Female Incidence and Prevalence of Urinary Bladder Disorders by Type and Geographical Distribution
  • Table 2-12: Estimated Female Statistics Concerning Lifestyle Patterns Contributing to Disease by Type of Behavior and Geographical Distribution
  • Table 3-1: The World Market for Autoimmune Disease Drugs for Women by Type 1997-2007
  • Figure 3-1: The World Market for Autoimmune Disease Drugs for Women Revenues by Type 1997-2007
  • Table 3-2: The World Market for Autoimmune Disease Drugs for Women Market Share by Type 1997-2007
  • Figure 3-2: The World Market for Autoimmune Disease Drugs for Women Share by Type 2002 & 2007
  • Table 3-3: The World Market for Autoimmune Disease Drugs for Women Revenues by Geographical Region 1997-2007
  • Table 3-4: The World Market for Autoimmune Disease Drugs for Women Share by Geographical Region 1997-2007
  • Figure 3-3: The World Market for Autoimmune Disease Drugs for Women Share by Geographic Region 2002 and 2007
  • Table 3-5: Products in Development for Selected Autoimmune Diseases 2002
  • Table 3-6: The World Market for Autoimmune Disease Drugs for Women Revenues and Market Share by Supplier 2002
  • Figure 3-4: The World Market for Autoimmune Disease Drugs for Women Market Share by Leading Supplier 2002
  • Table 4-1: The World Market for Cancer Drugs for Women by Type 1997-2007
  • Figure 4-1: The World Market for Cancer Drugs for Women Revenues by Type 1997-2007
  • Table 4-2: The World Market for Cancer Drugs for Women Market Share by Type 1997-2007
  • Figure 4-2: The World Market for Cancer Drugs for Women Share by Type 2002 and 2007
  • Table 4-3: The World Market for Cancer Drugs for Women Revenues by Geographical Region 1997-2007
  • Table 4-4: The World Market for Cancer Drugs for Women Share by Geographical Region 1997-2007
  • Figure 4-3: The World Market for Cancer Drugs for Women Share Percentage 2002 and 2007
  • Table 4-5: Products in Development for Women’s Cancers
  • Table 4-6: The World Market for Cancer Drugs for Women Revenues and Market Share by Supplier 2002
  • Figure 4-4: The World Market for Cancer Drugs for Women Market Share by Leading Supplier 2002
  • Table 5-1: The World Market for Gynecological Infection and Sexually Transmitted Disease Drugs for Women by Type 1997-2007
  • Figure 5-1: The World Market for Gynecological Infection and Sexually Transmitted Disease Drugs for Women Revenues by Type 1997-2007
  • Table 5-2: The World Market for Gynecological Infection and Sexually Transmitted Disease Drugs for Women, Market Share by Type 1997-2007
  • Figure 5-2: The World Market for Gynecological Infection and Sexually Transmitted Disease Drugs for Women Share by Type 2002 and 2007
  • Table 5-3: The World Market for Gynecological Infection and Sexually Transmitted Disease Drugs for Women Revenues by Geographical Region 1997-2007
  • Table 5-4: The World Market for Gynecological Infection and Sexually Transmitted Disease Drugs for Women Share by Geographical Region 1997-2007
  • Figure 5-3: The World Market for Gynecological Infection and Sexually Transmitted Disease Drugs for Women Share by Geographic Region 2002 and 2007
  • Table 5-5: Products in Development for Women’s Gynecological Infections and Sexually Transmitted Diseases
  • Table 5-6: The World Market for Gynecological Infection and Sexually Transmitted Disease Drugs for Women Revenues and Market Share by Supplier 2002
  • Figure 5-4: The World Market for Gynecological Infection and Sexually Transmitted Disease Drugs for Women Market Share by Leading Supplier 2002
  • Table 6-1: Selected Oral Contraceptives Available 2002
  • Table 6-2: Selected Hormone Replacement Therapies
  • Table 6-3: The World Market for Hormone-Related Disorder Drugs for Women by Type 1997-2007
  • Figure 6-1: The World Market for Hormone-Related Disorder Drugs for Women by Type 1997-2007
  • Table 6-4: The World Market for Hormone-Related Disorder Drugs for Women Market Share by Type 1997-2007
  • Figure 6-2: The World Market for Hormone-related Disorder Drugs for Women Share by Type 2002 and 2007
  • Table 6-5: The World Market for Hormone-Related Disorder Drugs for Women Revenues by Geographical Region 1997-2007
  • Table 6-6: The World Market for Hormone-Related Disorder Drugs for Women Share by Geographical Region 1997-2007
  • Figure 6-3: The World Market for Hormone-Related Disorder Drugs for Women Share by Geographic Region 2002 and 2007
  • Table 6-7: Hormonal Preparations in Research and Development for Women
  • Table 6-8: The World Market for Hormone-Related Disorder Drugs for Women Revenues and Market Share by Supplier 2002
  • Figure 6-4: The World Market for Hormone-Related Disorder Drugs for Women Market Share by Leading Supplier 2002
  • Table 7-1: The World Market for Osteoporosis Drugs for Women Revenues by Type 1997-2007
  • Figure 7-1: The World Market for Osteoporosis Drugs for Women Revenues by Type 1997-2007
  • Table 7-2: The World Market for Osteoporosis Drugs for Women, Market Share by Type 1997-2007
  • Figure 7-2: The World Market for Osteoporosis Drugs for Women Share by Type 2002 and 2003
  • Table 7-3: The World Market for Osteoporosis Drugs for Women Revenues by Geographical Region 1997-2007
  • Table 7-4: The World Market for Osteoporosis Drugs for Women Share by Geographical Region 1997-2007
  • Figure 7-3: The World Market for Osteoporosis Drugs for Women Share by Geographic Region 2002 and 2007
  • Table 7-5: Products in Development for Osteoporosis
  • Table 7-6: The World Market for Osteoporosis Drugs for Women Revenues and Market Share by Supplier 2002
  • Figure 7-4: The World Market for Osteoporosis Drugs for Women Market Share by Leading Supplier 2002
  • Table 8-1: Medications That Can Affect Urination
  • Table 8-2: The World Market for Urinary Bladder Disorder Drugs for Women Revneues by Type 1997-2007
  • Figure 8-1: The World Market for Urinary Bladder Disorder Drugs for Women Revenues by Type 1997-2007
  • Table 8-3: The World Market for Urinary Bladder Disorder Drugs for Women Market Share by Type 1997-2007
  • Figure 8-2: The World Market for Urinary Bladder Disorder Drugs for Women Share by Type 2002 and 2007
  • Table 8-4: The World Market for Urinary Bladder Disorder Drugs for Women Revenues by Geographical Region 1997-2007
  • Table 8-5: The World Market for Urinary Bladder Disorder Drugs for Women Share by Geographical Region 1997-2007
  • Figure 8-3: The World Market for Urinary Bladder Disorder Drugs for Women Share by Geographic Region 2002 and 2007
  • Table 8-6: Products in Development for Urinary Disorders
  • Table 8-7: The World Market for Urinary Bladder Disorder Drugs for Women Revenues and Market Share by Supplier 2002
  • Figure 8-4: The World Market for Urinary Bladder Disorder Drugs for Women Market Share by Leading Supplier 2002
  • Table 10-1: The Worldwide Market for Women’s Healthcare, Revenues by Segment, 1997-2007
  • Figure 10-1: The Market for Women’s Healthcare Revenues by Segment 1997-2007
  • Table 10-2: The Market for Women’s Healthcare Market Share by Segment 1997-2007
  • Figure 10-2: The Market for Women’s Healthcare Market Share by Type 2002 and 2007
  • Table 10-3: The Market for Women’s Healthcare Revenues and Segments of Participation by Leading Market Participants 2002

 

    Cell and Gene Therapy Market Dynamics by Disease Type: Development, Trends, and Forecasts, 4th Edition (2024-2030)
    April 11, 2025
    Cell and Gene Therapy Market Deals: Investment, M&A, and Partnerships, 2021-2025 (3rd Edition)
    February 13, 2025
    Cell and Gene Therapy Deals Analysis, 2021-2024
    June 3, 2024
    Cell Therapy and Gene Therapy Markets (Markets by Disease Type), 2023-2029
    April 30, 2024

Related products

  • Placeholder image

    Worldwide Market for Prescription Dermatological Drugs – 4th Edition, The

    $3,500.00 – $7,000.00
  • Placeholder image

    Outsourcing in Drug Development – The Contract Research Market from Preclinical to Phase III

    $3,500.00 – $7,000.00
  • Placeholder image

    Growth Factors: Indications, Products, and Markets

    $2,625.00 – $5,250.00
  • Placeholder image

    OTC Women’s Health: A Supplement to Women’s Health, 3rd Edition

    $1,496.00 – $2,992.00

Contact Us

  • 671 North Glebe Road, Suite 1610 Arlington, VA 22203 United States

  • Email Us

  • 703-778-3080

  • Send us a message!

Pay Invoice

  • Pay an Invoice by Credit Card

Follow Us!

Latest Blogs

  • 4 Fascinating Facts About Cancer Diagnostics March 4, 2025
  • Food Animal Diagnostics Market: Spotlight on Disease Testing Amid Bird Flu Surge February 20, 2025
  • Custom Competitive Intelligence (CI) Research: A New Strategic Imperative For Lab Diagnostics Companies  February 19, 2025
  • The Rise of Pharmacodiagnostics in the $10 Billion Global Cancer Diagnostics Market February 1, 2025
  • IVD Trends to Watch: Personalized Medicine Adds Precision to Diagnostic Testing January 2, 2025

Sitemap

  • Home
  • About
  • Blog
  • Contact
  • Sitemap

Your Data and Privacy

  • View our Privacy Policy
  • GDPR Statement
  • Privacy Settings

About Us

Kalorama Information, part of Science and Medicine Group, has been a leading publisher of market research in medical markets, including the biotechnology, diagnostics, medical device, and pharmaceutical industries for more than 30 years. Our comprehensive, timely, quality research and innovative approach to analysis and presentation of market intelligence have made Kalorama Information a premier source of market information for top industry decision makers.

Visit Science and Medicine Group
In Vitro Diagnostic Tests and Systems: The World Outside the United StatesWorld Market for Anti-infectives Volume III: The World Market for Antiviral...
Scroll to top